國家衛生研究院 NHRI:Item 3990099045/3091
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 857757      Online Users : 797
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/3091


    Title: On statistical evaluation of the linearity in assay validation
    Authors: Hsieh, E;Liu, JP
    Contributors: Division of Biostatistics and Bioinformatics
    Abstract: Linearity is one of the most important characteristics for evaluation of the accuracy in assay validation. The current statistical method for evaluation of the linearity recommended by the Clinical Laboratory Standard Institute (CLSI) guideline EP6-A is reviewed. The method directly compares the point estimates with the pre-specified allowable limit and completely ignores the sampling error of the point estimates. An alternative method for evaluation of linearity, proposed by Kroll et al. (2000), considers the statistical test procedure based on the average deviation from linearity (ADL). However this procedure is based on an inappropriate formulation of hypotheses for the evaluation of linearity. Consequently, the type I error rates of both current methods may be inflated for inference of linearity. To claim the linearity of analytical methods, we propose that the hypothesis of proving the linearity should be formulated as the alternative hypothesis. Furthermore, any procedures for assessment of linearity should be based on the sampling distributions of the proposed test statistics. Therefore, we propose a two one-sided test (TOST) procedure and a corrected Kroll's procedure. The simulation studies were conducted to empirically compare the size and power between current and proposed methods. The simulation results show that the proposed methods not only adequately control size but also provide sufficient power. A numeric example illustrates the proposed methods.
    Keywords: Pharmacology & Pharmacy;Statistics & Probability
    Date: 2008
    Relation: Journal of Biopharmaceutical Statistics. 2008;18(4):677-690.
    Link to: http://dx.doi.org/10.1080/10543400802071378
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1054-3406&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000257438900009
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=46749157535
    Appears in Collections:[Jen-Pei Liu(1998-2002)] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    000257438900009.pdf140KbAdobe PDF520View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback